Display Settings:

Format

Send to:

Choose Destination
    Hepatogastroenterology. 2008 Jan-Feb;55(81):93-7.

    Possible role of human papilloma virus infection in response to neoadjuvant therapy in patients with esophageal cancer.

    Source

    2nd Department of Surgery, Semmelweis University Budapest, Budapest, Hungary. bgabor@kut.sote.hu

    Abstract

    BACKGROUND/AIMS:

    Human papilloma virus (HPV) infection in esophageal cancer cases has been found in 0-70%, depending on different methods and geographical variances. Complete pathological response has been found in 30% of cases after neoadjuvant chemo-radiation (CRX). The aim of this study was to discover a possible relation between HPV-infection and response.

    METHODOLOGY:

    DNA was obtained from 26 esophageal cancer patients undergoing CRX and surgery. Polymerase chain reaction (PCR) and Southern Blot hybridization was used to detect HPV-infection (HPV-16 and -18). Clinicopathological parameters, disease-free survival and overall survival were also analyzed.

    RESULTS:

    Complete response (26.9%) and partial response (38.5%) after CRX was correlated significantly with better prognosis. Six patients had HPV-infection (3 from the CR- and 3 from PR-group).

    CONCLUSIONS:

    There was correlation between HPV-infection and response, but further analyses are necessary. Both responder-groups had a significantly better prognosis than non-responders.

    PMID:
    18507085
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk